Breast cancer stem cell cryopreservation protection agent and prepared cryopreservation protection kit
A technology of breast cancer stem cells and cryopreservation agents, applied in the field of stem cells, can solve the problems that it is difficult to effectively maintain the biological characteristics of breast cancer stem cells, and it is not suitable for cryopreservation of breast cancer stem cells, so as to promote commercialization and standardization, Strong tumorigenic ability and damage reduction effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0019] Example 1: Effects of different cryoprotectants on the survival rate and tumorigenicity of breast cancer stem cells after cryopreservation and resuscitation
[0020] 1. Experimental materials
[0021] Serum-containing medium for enrichment of MCF-7 breast cancer stem cells: Add 10% fetal bovine serum FBS and double antibody, galantamine and lycorine to 150nmol / L in DMEM / F12 culture medium, and the molar ratio of the two is 1 : 1. Add 10ml penicillin-streptomycin solution (100× double antibody, Beijing Legen Biotechnology Co., Ltd.) to 1L culture medium.
[0022] Serum-free medium for enrichment of MCF-7 breast cancer stem cells: DMEM / F12 culture medium with double antibody (concentration as above), recombinant human epidermal growth factor EGF 20g / L, bovine serum albumin BSA4g / L, insulin 5mg / L , B272% (1L medium plus 20ml 50X B27), galantamine and lycorine total 150nmol / L, the molar ratio of the two is 1:1.
[0023] Serum-free medium for passage of MCF-7 breast cance...
Embodiment 2
[0054] Embodiment 2: cryopreservation protection kit
[0055] A breast cancer stem cell cryopreservation protection kit, used in conjunction with fetal bovine serum FBS for cryopreservation and protection of MCF-7 breast cancer stem cells, including aliquoted serum-free medium lyophilized powder, which consists of the following Method preparation: Add conventional growth factors, galantamine and lycorine to DMEM / F12 culture medium to prepare EGF concentration of 20g / L, BSA concentration of 4g / L, insulin concentration of 5mg / L, concentration of 2%, The galantamine concentration is 75nmol / L, the lycorine concentration is 75nmol / L culture medium, at 37 ℃, 5% CO 2 Stored on a shaker under the conditions for 24h, freeze-dried.
[0056] The kit can also be provided with a subpackaged silica gel desiccant or preservative or antioxidant.
[0057] The cryopreservation agent provided by the invention is designed on the basis of MCF-7 breast cancer stem cell enrichment medium, which ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com